Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne L Miller

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Cardiology|May 8, 2007
Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritideWayne L Miller, Shaun Kurien, Karen T Warfield, et al.
Clinical Cardiology|May 12, 2007
Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathiesWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Journal of the American College of Cardiology|October 24, 2009
Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failureWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Clinical Chemistry|November 26, 2008
Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failureWayne L Miller, Karen A Hartman, Diane E Grill, et al.
Chest|January 14, 2004
Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary interventionWayne L Miller, Kirk N Garratt, Mary F Burritt, et al.
Mayo Clinic Proceedings|December 14, 2005
Risk factor implications of incidentally discovered uncomplicated bundle branch blockWayne L Miller, Karla V Ballman, David O Hodge, et al.
European Journal of Heart Failure|January 29, 2002
Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular functionWayne L Miller, Kent R Bailey, Susan A Weston, et al.
Heart (British Cardiac Society)|December 24, 2011
Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failureWayne L Miller, Karen A Hartman, Diane E Grill, et al.
ESC Heart Failure|September 13, 2024
Understanding the variability in red cell and plasma volume combinations can help guide management in heart failureWayne L Miller, Marat Fudim, Veraprapas Kittipibul, et al.
The Journal of Biological Chemistry|July 1, 2004
Biochemical characterization of WbpA, a UDP-N-acetyl-D-glucosamine 6-dehydrogenase involved in O-antigen biosynthesis in Pseudomonas aeruginosa PAO1Wayne L Miller, Cory Q Wenzel, Craig Daniels, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Cardiology|May 8, 2007
Lack of association between worsening renal function and mortality in heart failure patients treated with nesiritideWayne L Miller, Shaun Kurien, Karen T Warfield, et al.
Clinical Cardiology|May 12, 2007
Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathiesWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Journal of the American College of Cardiology|October 24, 2009
Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failureWayne L Miller, Karen A Hartman, Mary F Burritt, et al.
Clinical Chemistry|November 26, 2008
Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failureWayne L Miller, Karen A Hartman, Diane E Grill, et al.
Chest|January 14, 2004
Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary interventionWayne L Miller, Kirk N Garratt, Mary F Burritt, et al.
Mayo Clinic Proceedings|December 14, 2005
Risk factor implications of incidentally discovered uncomplicated bundle branch blockWayne L Miller, Karla V Ballman, David O Hodge, et al.
European Journal of Heart Failure|January 29, 2002
Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular functionWayne L Miller, Kent R Bailey, Susan A Weston, et al.
Heart (British Cardiac Society)|December 24, 2011
Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failureWayne L Miller, Karen A Hartman, Diane E Grill, et al.
ESC Heart Failure|September 13, 2024
Understanding the variability in red cell and plasma volume combinations can help guide management in heart failureWayne L Miller, Marat Fudim, Veraprapas Kittipibul, et al.
The Journal of Biological Chemistry|July 1, 2004
Biochemical characterization of WbpA, a UDP-N-acetyl-D-glucosamine 6-dehydrogenase involved in O-antigen biosynthesis in Pseudomonas aeruginosa PAO1Wayne L Miller, Cory Q Wenzel, Craig Daniels, et al.
Pageof 11